{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:07:56Z","timestamp":1793729276746,"version":"4.6.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>To better define the risk of malignancy transmission through organ transplantation, we review the Spanish experience on donor malignancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We analyzed the outcomes of recipients of organs obtained from deceased donors diagnosed with a malignancy during 2013\u20132018. The risk of malignancy transmission was classified as proposed by the Council of Europe.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Of 10\u2009076 utilized deceased donors, 349 (3.5%) were diagnosed with a malignancy. Of those, 275 had a past (n = 168) or current (n = 107) history of malignancy known before the transplantation of organs into 651 recipients. Ten malignancies met high-risk criteria. No donor-transmitted cancer (DTC) was reported after a median follow-up of 24 (interquartile range [IQR]: 19\u201325) mo. The other 74 donors were diagnosed with a malignancy after transplantation. Within this group, 64 donors (22 with malignancies of high or unacceptable risk) whose organs were transplanted into 126 recipients did not result in a DTC after a median follow-up of 26 (IQR: 22\u201337) mo, though a prophylactic transplantectomy was performed in 5 patients. The remaining 10 donors transmitted an occult malignancy to 16 of 25 recipients, consisting of lung cancer (n = 9), duodenal adenocarcinoma (n = 2), renal cell carcinoma (n = 2), extrahepatic cholangiocarcinoma (n = 1), prostate cancer (n = 1), and undifferentiated cancer (n = 1). After a median follow-up of 14 (IQR: 11\u201324) mo following diagnosis, the evolution was fatal in 9 recipients. In total, of 802 recipients at risk, 16 (2%) developed a DTC, which corresponds to 6 cases per 10 000 organ transplants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Current standards may overestimate the risk of malignancy transmission. DTC is an infrequent but difficult to eliminate complication.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004117","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:17:58Z","timestamp":1649168278000},"page":"1814-1823","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Malignancies in Deceased Organ Donors: The Spanish Experience"],"prefix":"10.1097","volume":"106","author":[{"given":"Beatriz","family":"Mah\u00edllo","sequence":"first","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Molano","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Navarro","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Catalana de Trasplantes, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Castro","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n Auton\u00f3mica de Trasplantes de Andaluc\u00eda, Sevilla, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Pont","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Vall d\u00b4Hebr\u00f3n, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado","family":"Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario 12 de Octubre, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gal\u00e1n","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario La Fe, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n Auton\u00f3mica de Trasplantes del Pa\u00eds Vasco, Bilbao, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Oliver","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario de Bellvitge, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mosteiro","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Complejo Hospitalario Universitario A Coru\u00f1a, A Coru\u00f1a, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Roque","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"P\u00e9rez-Redondo","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Puerta de Hierro, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Cid-Cumplido","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Ballesteros","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Daga","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Br\u00edgida","family":"Quind\u00f3s","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Central de Asturias, Oviedo, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Sancho","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Cl\u00ednica Universidad de Navarra, Pamplona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Royo-Villanova","sequence":"additional","affiliation":[{"name":"Coordinaci\u00f3n de Trasplantes, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bernab\u00e9","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Chac\u00f3n","sequence":"additional","affiliation":[{"name":"Servicio de Oncolog\u00eda M\u00e9dica, Hospital Universitario de Toledo, Toledo, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Coll","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Dom\u00ednguez-Gil","sequence":"additional","affiliation":[{"name":"Organizaci\u00f3n Nacional de Trasplantes, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1111\/j.1600-6143.2012.04138.x","article-title":"Continuously evaluating performance in deceased donation: the Spanish quality assurance program.","volume":"12","author":"de la Rosa","year":"2012","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s40620-020-00802-4","article-title":"Cancer post kidney transplant: the question of risk.","volume":"33","author":"Irish","year":"2020","journal-title":"J Nephrol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.","volume":"11","author":"Nalesnik","year":"2011","journal-title":"Am J Transplant"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/TP.0000000000003995","article-title":"Prevention and management of donor-transmitted cancer after liver transplantation: guidelines from the ILTS-SETH consensus conference.","volume":"106","author":"Dom\u00ednguez-Gil","year":"2022","journal-title":"Transplantation"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1148\/rg.2016150175","article-title":"Malignancy after solid organ transplantation: comprehensive imaging review.","volume":"36","author":"Katabathina","year":"2016","journal-title":"Radiographics"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00007890-200212270-00001","article-title":"Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation.","volume":"74","author":"Feng","year":"2002","journal-title":"Transplantation"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1067\/msy.2001.117102","article-title":"Transmission of donor cancer into cardiothoracic transplant recipients.","volume":"130","author":"Buell","year":"2001","journal-title":"Surgery"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.TP.0000076094.64973.D8","article-title":"Donors with central nervous system malignancies: are they truly safe?","volume":"76","author":"Buell","year":"2003","journal-title":"Transplantation"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.transproceed.2004.12.118","article-title":"Donor kidneys with small renal cell cancers: can they be transplanted?","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007890-200012270-00014","article-title":"First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.","volume":"70","author":"Kauffman","year":"2000","journal-title":"Transplantation"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00007890-200211270-00012","article-title":"Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.","volume":"74","author":"Birkeland","year":"2002","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/TP.0b013e31816c2d42","article-title":"The Italian multiorgan donor cancer screening protocol: 2002-2005 experience.","volume":"85","author":"Zucchini","year":"2008","journal-title":"Transplantation"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007890-200208150-00011","article-title":"Transplant tumor registry: donor related malignancies.","volume":"74","author":"Myron Kauffman","year":"2002","journal-title":"Transplantation"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.tp.0000267919.93425.fb","article-title":"Deceased donors with a past history of malignancy: an organ procurement and transplantation network\/united network for organ sharing update.","volume":"84","author":"Kauffman","year":"2007","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/TP.0b013e31816c2f55","article-title":"The Spanish National Transplant Organization (ONT) tumor registry.","volume":"85","author":"Garrido","year":"2008","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e318272df41","article-title":"Cancer transmission from organ donors-unavoidable but low risk.","volume":"94","author":"Desai","year":"2012","journal-title":"Transplantation"},{"issue":"10S","key":"R21-20250604","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007890-201211271-01014","article-title":"6-year survey of organ donors with malignancies in Germany.","volume":"94","author":"Moench","year":"2012","journal-title":"Transplantation"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.9460","article-title":"Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry.","volume":"101","author":"Desai","year":"2014","journal-title":"Br J Surg"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40620-018-00573-z","article-title":"How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network.","volume":"32","author":"Eccher","year":"2019","journal-title":"J Nephrol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: A report of the Disease Transmission Advisory Committee.","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s40620-020-00775-4","article-title":"Donor-transmitted cancer in kidney transplant recipients: a systematic review.","volume":"33","author":"Eccher","year":"2020","journal-title":"J Nephrol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/tri.13989","article-title":"Cancer transmissions and non-transmissions from solid organ transplantation in an Australian cohort of deceased and living organ donors.","volume":"34","author":"Hedley","year":"2021","journal-title":"Transpl Int"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/ajt.14104","article-title":"How Spain reached 40 deceased organ donors per million population.","volume":"17","author":"Matesanz","year":"2017","journal-title":"Am J Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2009.02700.x","article-title":"Donor-derived disease transmission events in the United States: data reviewed by the OPTN\/UNOS Disease Transmission Advisory Committee.","volume":"9","author":"Ison","year":"2009","journal-title":"Am J Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1097\/TXD.0000000000000953","article-title":"Whole body CT imaging in deceased donor screening for malignancies.","volume":"5","author":"Mensink","year":"2019","journal-title":"Transplant Direct"},{"key":"R33-20250604","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13045","article-title":"Rapid screening for malignancy in organ donors: 15-year experience with the Verona \u201cAlert\u201d protocol and review of the literature.","volume":"31","author":"Eccher","year":"2017","journal-title":"Clin Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0041-1345(98)01989-7","article-title":"Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report.","volume":"31","author":"Chui","year":"1999","journal-title":"Transplant Proc"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1432-2277.2001.tb00070.x","article-title":"The fate of recipients of organs from donors with diagnosis of primary brain tumor.","volume":"14","author":"Pokorna","year":"2001","journal-title":"Transpl Int"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/TP.0000000000002994","article-title":"Safety of donation from brain-dead organ donors with central nervous system tumors: analysis of transplantation outcomes in Korea.","volume":"104","author":"Lee","year":"2020","journal-title":"Transplantation"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1600-6143.2010.03130.x","article-title":"How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data.","volume":"10","author":"Watson","year":"2010","journal-title":"Am J Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1215\/S1152851703000474","article-title":"Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature.","volume":"6","author":"Armanios","year":"2004","journal-title":"Neuro Oncol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"e13597","DOI":"10.1111\/ctr.13597","article-title":"Renal cell carcinoma suspected at time of organ donation 2008-2016: a report of the OPTN ad hoc Disease Transmission Advisory Committee Registry.","volume":"33","author":"Pavlakis","year":"2019","journal-title":"Clin Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation.","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.tp.0000247794.50318.4a","article-title":"A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia.","volume":"83","author":"Taioli","year":"2007","journal-title":"Transplantation"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.transproceed.2007.05.069","article-title":"Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003-2005 period.","volume":"39","author":"Pretagostini","year":"2007","journal-title":"Transplant Proc"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/tri.12962","article-title":"Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?","volume":"30","author":"Pezzati","year":"2017","journal-title":"Transpl Int"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.lts.2003.09.024","article-title":"If the donor had an early-stage genitourinary carcinoma and the liver has already been implanted, should we perform the transplantectomy?","volume":"9","author":"Serralta","year":"2003","journal-title":"Liver Transpl"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/tri.12693","article-title":"Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.","volume":"29","author":"Pandanaboyana","year":"2016","journal-title":"Transpl Int"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00007890-200108150-00034","article-title":"Fate of a renal tubulopapillary adenoma transmitted by an organ donor.","volume":"72","author":"Barrou","year":"2001","journal-title":"Transplantation"},{"key":"R47-20250604","first-page":"298","article-title":"Transferral of extrathoracic donor neoplasm by the cardiac allograft.","volume":"16","author":"Sack","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00869005","article-title":"Cerebral metastases of an allogenic renal cell carcinoma in a heart recipient without renal cell carcinoma.","volume":"243","author":"Meyding-Lamad\u00e9","year":"1996","journal-title":"J Neurol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.juro.2007.10.057","article-title":"Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors.","volume":"179","author":"Yin","year":"2008","journal-title":"J Urol"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.transproceed.2012.06.030","article-title":"The use of neoplastic donors to increase the donor pool.","volume":"44","author":"Fiaschetti","year":"2012","journal-title":"Transplant Proc"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.transproceed.2018.02.129","article-title":"Prostate cancer in deceased organ donors: loss of organ or transplantation with active surveillance.","volume":"50","author":"Skalski","year":"2018","journal-title":"Transplant Proc"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/ajt.12683","article-title":"Cancers among United States organ donors: a comparison of transplant and cancer registry diagnoses.","volume":"14","author":"Engels","year":"2014","journal-title":"Am J Transplant"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1600-6143.2010.03198.x","article-title":"Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines.","volume":"10","author":"D\u2019Errico-Grigioni","year":"2010","journal-title":"Am J Transplant"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2013.10.003","article-title":"Prostate cancer in deceased organ donors: a review.","volume":"28","author":"Doerfler","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"378","DOI":"10.14309\/ajg.0000000000000135","article-title":"Periesophageal lymph node metastasis of prostate adenocarcinoma from liver transplant donor.","volume":"114","author":"S\u00e1nchez-Montes","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jama.1997.03540260047034","article-title":"Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation.","volume":"277","author":"Loh","year":"1997","journal-title":"JAMA"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:01:22Z","timestamp":1749063682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004117","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}